Cargando…

Differential Expression of E2F Transcription Factors and Their Functional and Prognostic Roles in Human Prostate Cancer

Given the tumor heterogeneity, most of the current prognostic indicators cannot accurately evaluate the prognosis of patients with prostate cancer, and thus, the best opportunity to intervene in the progression of this disease is missed. E2F transcription factors (E2Fs) have been reported to be invo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Zhaodong, Mo, Rujun, Cai, Shanghua, Feng, Yuanfa, Tang, Zhenfeng, Ye, Jianheng, Liu, Ren, Cai, Zhiduan, Zhu, Xuejin, Deng, Yulin, Zou, Zhihao, Wu, Yongding, Cai, Zhouda, Liang, Yuxiang, Zhong, Weide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068940/ https://www.ncbi.nlm.nih.gov/pubmed/35531101 http://dx.doi.org/10.3389/fcell.2022.831329

Ejemplares similares

The prognostic roles of CYP19A1 expression in bladder cancer patients of different genders
por: Cai, Shanghua, et al.
Publicado: (2021)

Integrated analysis reveals prognostic value and progression-related role of AMIGO2 in prostate cancer
por: Han, Zhaodong, et al.
Publicado: (2022)

Aberrant Expression of Citrate Synthase is Linked to Disease Progression and Clinical Outcome in Prostate Cancer
por: Cai, Zhiduan, et al.
Publicado: (2020)

Prognostic implication of heterogeneity and trajectory progression induced by enzalutamide in prostate cancer
por: Feng, Yuanfa, et al.
Publicado: (2023)

Down-regulation of ACACA suppresses the malignant progression of Prostate Cancer through inhibiting mitochondrial potential
por: Zhang, Hui, et al.
Publicado: (2021)

Metformin escape in prostate cancer by activating the PTGR1 transcriptional program through a novel super-enhancer
por: Ye, Jianheng, et al.
Publicado: (2023)

Identification and Validation of a PPP1R12A-Related Five-Gene Signature Associated With Metabolism to Predict the Prognosis of Patients With Prostate Cancer
por: Zou, Zhihao, et al.
Publicado: (2021)

TFEB Promotes Prostate Cancer Progression via Regulating ABCA2-Dependent Lysosomal Biogenesis
por: Zhu, Xuejin, et al.
Publicado: (2021)

Corrigendum: TFEB Promotes Prostate Cancer Progression via Regulating ABCA2-Dependent Lysosomal Biogenesis
por: Zhu, Xuejin, et al.
Publicado: (2021)

A HIF1α-GPD1 feedforward loop inhibits the progression of renal clear cell carcinoma via mitochondrial function and lipid metabolism
por: Liu, Ren, et al.
Publicado: (2021)

Identification and experimental validation of a tumor-infiltrating lymphocytes–related long noncoding RNA signature for prognosis of clear cell renal cell carcinoma
por: Deng, Yulin, et al.
Publicado: (2022)

Prediction of Biochemical Recurrence-Free Survival of Prostate Cancer Patients Leveraging Multiple Gene Expression Profiles in Tumor Microenvironment
por: Zhou, Rui, et al.
Publicado: (2021)

Genome-Scale CRISPR-Cas9 Transcriptional Activation Screening in Metformin Resistance Related Gene of Prostate Cancer
por: Chen, Jiahong, et al.
Publicado: (2021)

The ALDOA Metabolism Pathway as a Potential Target for Regulation of Prostate Cancer Proliferation
por: Kuang, Qiwen, et al.
Publicado: (2021)

FCGR3A: A new biomarker with potential prognostic value for prostate cancer
por: Zha, Zeyu, et al.
Publicado: (2022)

A prognostic signature consisting of N6-methyladenosine modified mRNAs demonstrates clinical potential in prediction of biochemical recurrence and guidance on precision therapy in prostate cancer
por: Lu, Jianming, et al.
Publicado: (2023)

Identification and Validation of FGF-Related Prognostic Signatures in Prostate Cancer
por: Ye, Yongkang, et al.
Publicado: (2023)

Comprehensive Transcriptomic Analysis Reveals Prognostic Value of an EMT-Related Gene Signature in Colorectal Cancer
por: Mo, Shaobo, et al.
Publicado: (2021)

Current role of prostate-specific membrane antigen-based imaging and radioligand therapy in castration-resistant prostate cancer
por: Chen, Jiaxian, et al.
Publicado: (2022)

Offsetting Expression Profiles of Prognostic Markers in Prostate Tumor vs. Its Microenvironment
por: Jia, Zhenyu, et al.
Publicado: (2019)

Comprehensive Analysis and Identification of Prognostic Biomarkers and Therapeutic Targets Among FAM83 Family Members for Gastric Cancer
por: Zhang, Tianhao, et al.
Publicado: (2021)

Increased expression of immediate early response gene 3 protein promotes aggressive progression and predicts poor prognosis in human bladder cancer
por: Ye, Jianheng, et al.
Publicado: (2018)

Identification of lipid metabolism-associated genes as prognostic biomarkers based on the immune microenvironment in hepatocellular carcinoma
por: Gu, Xiangqian, et al.
Publicado: (2022)

Analysis of DNA Repair-Related Prognostic Function and Mechanism in Gastric Cancer
por: Wang, Liqiang, et al.
Publicado: (2022)

Mitochondrion-associated protein peroxiredoxin 3 promotes benign prostatic hyperplasia through autophagy suppression and pyroptosis activation
por: Jiang, Min-Yao, et al.
Publicado: (2017)

FBXO5 acts as a novel prognostic biomarker for patients with cervical cancer
por: Jiang, Shan, et al.
Publicado: (2023)

A Candidate Prognostic Biomarker Complement Factor I Promotes Malignant Progression in Glioma
por: Cai, Xiaomin, et al.
Publicado: (2021)

Prognostic Value of a Ferroptosis-Related Gene Signature in Patients With Head and Neck Squamous Cell Carcinoma
por: He, Dongsheng, et al.
Publicado: (2021)

ALKBH1-8 and FTO: Potential Therapeutic Targets and Prognostic Biomarkers in Lung Adenocarcinoma Pathogenesis
por: Wu, Geting, et al.
Publicado: (2021)

A reactive oxygen species–related signature to predict prognosis and aid immunotherapy in clear cell renal cell carcinoma
por: Liu, Hongxiang, et al.
Publicado: (2023)

SNHG10 Is a Prognostic Biomarker Correlated With Immune Infiltrates in Prostate Cancer
por: Chen, Qiang, et al.
Publicado: (2021)

Development and validation of a copper-related gene prognostic signature in hepatocellular carcinoma
por: Shi, Haoting, et al.
Publicado: (2023)

A Novel Ferroptosis-Related Prognostic Signature Reveals Macrophage Infiltration and EMT Status in Bladder Cancer
por: Yan, Yilin, et al.
Publicado: (2021)

Development of an Oxidative Phosphorylation-Related and Immune Microenvironment Prognostic Signature in Uterine Corpus Endometrial Carcinoma
por: Liu, Jinhui, et al.
Publicado: (2021)

The Prognostic Model Based on Tumor Cell Evolution Trajectory Reveals a Different Risk Group of Hepatocellular Carcinoma
por: Wang, Haoren, et al.
Publicado: (2021)

Downregulated Ferroptosis-Related Gene STEAP3 as a Novel Diagnostic and Prognostic Target for Hepatocellular Carcinoma and Its Roles in Immune Regulation
por: Yan, Yuanliang, et al.
Publicado: (2021)

EID3 Promotes Cancer Stem Cell-Like Phenotypes in Osteosarcoma through the Activation of PI3K-AKT Signaling Pathway
por: Wang, Yan, et al.
Publicado: (2022)

High-Fat Diet Induced Gut Microbiota Alterations Associating With Ghrelin/Jak2/Stat3 Up-Regulation to Promote Benign Prostatic Hyperplasia Development
por: Gu, Meng, et al.
Publicado: (2021)

Development of a Metastasis-Related Immune Prognostic Model of Metastatic Colorectal Cancer and Its Usefulness to Immunotherapy
por: Luo, Zhiwen, et al.
Publicado: (2021)

Universal cutoff for tumor mutational burden in predicting the efficacy of anti-PD-(L)1 therapy for advanced cancers
por: Mo, Shu-Fen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_doicprmb5ncjdri0745lsm9cdf